Literature DB >> 18713635

Molecular cloning and differential expression pattern of two structural variants of the crustacean hyperglycemic hormone family from the mud crab Scylla olivacea.

Kuo-Wei Tsai1, Su-Jung Chang, Hsin-Ju Wu, Hsin-Yi Shih, Chun-Hao Chen, Chi-Ying Lee.   

Abstract

Two full-length cDNA sequences encoding a crustacean hyperglycemic hormone (CHH) precursor were cloned from tissues of the mud crab Scylla olivacea. Sco-CHH (S. olivacea CHH) was cloned from eyestalk ganglia, whereas Sco-CHH-L (S. olivacea CHH-like peptide) was cloned from extra-eyestalk tissues (pericardial organ and thoracic ganglia). Each conceptually translated precursor is expected to be processed into a signal peptide, a CHH precursor-related peptide (CPRP), and a mature CHH or CHH-like peptide. The two precursors are identical in amino acid sequence through the 40th residue of the mature peptide, but different from each other substantially in the C-terminus. Both CHH variants contain the six highly conserved cysteine residues characteristic of the CHH family peptides, and share higher sequence identities with other brachyuran CHH sequences than with those of other taxonomic groups. As determined by reverse transcription-polymerase chain reaction (RT-PCR), the transcripts of Sco-CHH and Sco-CHH-L were present in eyestalk ganglia and several extra-eyestalk tissues (the thoracic ganglia, pericardial organ, brain, circumesophageal connectives, and gut). Sco-CHH was the predominant form in eyestalk ganglia, while Sco-CHH-L was the predominant form in several extra-eyestalk tissues. Neither transcript was expressed in the muscle, hepatopancreas, ovary, testis, heart, or gill. Antisera were raised against synthetic peptides corresponding to a stretch of sequence-specific to the C-terminus of Sco-CHH or Sco-CHH-L. Western blot analyses of tissues expressing Sco-CHH and Sco-CHH-L detected a Sco-CHH immunoreactive protein in the sinus gland, and a Sco-CHH-L immunoreactive protein in the pericardial organ. Immunohistochemical analyses of the eyestalk ganglia localized both Sco-CHH and Sco-CHH-L immunoreactivity to the sinus gland, and only Sco-CHH immunoreactivity to the X-organ somata; analyses of the pericardial organs also localized both Sco-CHH and Sco-CHH-L immunoreactivity to the anterior and posterior bars, as well as to longitudinal trunks joining the two bars. The combined data provided supporting evidence that Sco-CHH and Sco-CHH-L are co-localized in the same tissue.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18713635     DOI: 10.1016/j.ygcen.2008.07.014

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  4 in total

1.  GABA and GAD expression in the X-organ sinus gland system of the Procambarus clarkii crayfish: inhibition mediated by GABA between X-organ neurons.

Authors:  Paola Pérez-Polanco; Julieta Garduño; Jorge Cebada; Natanael Zarco; José Segovia; Mónica Lamas; Ubaldo García
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2011-05-31       Impact factor: 1.836

2.  Structure-Based Functional Analysis of a Hormone Belonging to an Ecdysozoan Peptide Superfamily: Revelation of a Common Molecular Architecture and Residues Possibly for Receptor Interaction.

Authors:  Yun-Ru Chen; Nai-Wan Hsiao; Yi-Zong Lee; Shiau-Shan Huang; Chih-Chun Chang; Jyuan-Ru Tsai; Hui-Chen Lin; Jean-Yves Toullec; Chi-Ying Lee; Ping-Chiang Lyu
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

3.  Functional Assessment of Residues in the Amino- and Carboxyl-Termini of Crustacean Hyperglycemic Hormone (CHH) in the Mud Crab Scylla olivacea Using Point-Mutated Peptides.

Authors:  Chun-Jing Liu; Shiau-Shan Huang; Jean-Yves Toullec; Cheng-Yen Chang; Yun-Ru Chen; Wen-San Huang; Chi-Ying Lee
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

Review 4.  The Crustacean Hyperglycemic Hormone Superfamily: Progress Made in the Past Decade.

Authors:  Hsiang-Yin Chen; Jean-Yves Toullec; Chi-Ying Lee
Journal:  Front Endocrinol (Lausanne)       Date:  2020-10-01       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.